Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on C Acid. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN106699628A reveals efficient levulinic acid conversion. Lower temperature, high yield pyrrolidone synthesis for reliable supply chain.
Patent CN115947759A reveals a one-pot Remdesivir synthesis reducing steps and cost. Discover supply chain advantages and high-purity manufacturing insights.
Novel route for Iopamidol production via acylated intermediate. High purity, reduced impurities, and cost-effective manufacturing for global supply chains.
Patent CN112375015A reveals a high-yield, three-step synthesis for di-tert-butyloxycarbonylamino oxyacetic acid, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturers.
Patent CN110092735B reveals a high-yield Negishi coupling route for Eluxadoline intermediates, offering significant cost reduction and scalable manufacturing for pharmaceutical clients.
Patent CN112442060B enables mild copper catalysis for gamma-aminoboronic acid esters. Achieve high purity pharmaceutical intermediates with reduced operational complexity and enhanced supply reliability.
Patent CN103626791B details a cost-effective Grignard route for high-purity 3-amino-4-fluorophenylboronic acid, offering supply chain stability and reduced manufacturing costs.
Novel synthesis route for S-N-protected azetidine-2-carboxylic acid via CN102477007A. Offers safer reduction methods and scalable manufacturing for pharmaceutical intermediates.
Patent CN113582865A details a novel copper-catalyzed route for alpha,alpha-disubstituted chiral amino acid esters, offering high enantioselectivity and streamlined manufacturing for API intermediates.
Patent CN107629101B reveals efficient synthesis route. Offers cost reduction and high purity for pharmaceutical intermediates manufacturing supply chain.
Patent CN103483341A reveals a streamlined route to 2,4-pyrrolidine-diketones via Diels-Alder cyclization, offering cost-effective API intermediate manufacturing solutions.
Patent CN113773227A details a visible-light mediated method for epsilon-cyano carboxylic acids using CO2. Offers cost-effective pharma intermediate manufacturing.
Patent CN103467334B reveals high-yield synthesis for N-(2-chloro)-propionyl-glutamine. Offers cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Novel catalytic hydrogenation route reduces impurities and enhances yield for high-purity 3-aminosalicylic acid manufacturing supply chain stability.
Patent CN120794988A reveals efficient chiral phosphoric acid catalysis for high-purity indole derivatives, offering significant supply chain and cost advantages.
Novel synthesis of chiral optical pure alkynylamide substituted α,β-diamino acid derivatives via Rh-catalyzed three-component reaction for potent anticancer applications.
Patent CN112724189A details a novel semi-synthetic route for Chenodeoxycholic Acid from waste bile acids, offering significant cost reduction and supply chain stability for API manufacturers.
Novel one-step synthesis reduces cost and steps for high-purity pharmaceutical intermediates supply chain optimization and commercial scale production.
Novel furandione route offers 60.9% yield and 99.5% purity for obesity drug intermediate, ensuring scalable supply chain solutions.
Patent CN110423261B reveals a novel synthesis route for 7-ketolithocholic acid from hyocholic acid, offering high purity and significant cost reduction in bile acid manufacturing.